Teladoc Health (NYSE:TDOC) Price Target Raised to $11.50

Teladoc Health (NYSE:TDOC - Free Report) had its target price increased by Bank of America from $10.50 to $11.50 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a neutral rating on the health services provider's stock.

Several other research analysts have also issued reports on TDOC. Deutsche Bank Aktiengesellschaft raised their target price on Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research report on Friday, November 1st. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research note on Friday, November 15th. They issued a "buy" rating and a $14.00 price objective on the stock. TD Cowen cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday, October 31st. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Finally, Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an "overweight" rating in a research report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $11.97.

Teladoc Health Trading Up 7.0 %

Shares of NYSE:TDOC traded up $0.91 during midday trading on Thursday, hitting $13.86. 15,197,359 shares of the stock were exchanged, compared to its average volume of 5,500,938. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $21.74. The business's 50-day moving average price is $10.05 and its 200 day moving average price is $9.14. The stock has a market capitalization of $2.39 billion, a price-to-earnings ratio of -2.40 and a beta of 1.05.

Insider Activity at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.95% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently modified their holdings of the business. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock worth $15,617,000 after purchasing an additional 228,004 shares during the period. The Manufacturers Life Insurance Company raised its holdings in shares of Teladoc Health by 195.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock valued at $932,000 after acquiring an additional 63,028 shares in the last quarter. Jennison Associates LLC bought a new stake in shares of Teladoc Health during the 3rd quarter valued at about $1,544,000. Massachusetts Financial Services Co. MA increased its position in shares of Teladoc Health by 477.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock worth $3,397,000 after purchasing an additional 305,961 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock valued at $36,042,000 after purchasing an additional 56,864 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.